Literature DB >> 20536297

Thymus hormones as prospective anti-inflammatory agents.

Sergey M Lunin1, Elena G Novoselova.   

Abstract

IMPORTANCE OF THE FIELD: Inflammatory diseases are characterized by severe immune imbalances, leading to excessive or inappropriate release of mediators, which, in turn, result in massive damage to organs and systems. Effective means to control inappropriate immune reactions are often life-critical needs. Available data on the role of thymus-derived hormones in inflammation show their great potential. AREAS COVERED IN THIS REVIEW: The review aims to systematize information for the last two decades on immune system regulation by thymic peptide hormones, with a primary focus on the role of these hormones in the systemic inflammatory response and inflammatory diseases. Anti-inflammatory potential of three thymic hormones - thymulin, thymosin-alpha, and thymopoietin - is discussed, reviewing recently published clinical and experimental studies. WHAT THE READER WILL GAIN: Our analysis revealed the regulation of inflammatory processes via thymic hormones that could be prospective for therapeutic application. This regulation may be mediated through thymic hormone effects on peripheral immune cell activities and bidirectional coupling between thymic hormones and the hypothalamic-pituitary-adrenal axis. TAKE-HOME MESSAGE: In view of the role of thymic hormones in immune and neuroendocrine systems, they could be suitable as therapeutic agents for inflammation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20536297     DOI: 10.1517/14728222.2010.499127

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  10 in total

Review 1.  Cell Senescence and Central Regulators of Immune Response.

Authors:  Sergey M Lunin; Elena G Novoselova; Olga V Glushkova; Svetlana B Parfenyuk; Tatyana V Novoselova; Maxim O Khrenov
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

2.  Anti-inflammatory effects of IKK inhibitor XII, thymulin, and fat-soluble antioxidants in LPS-treated mice.

Authors:  E G Novoselova; M O Khrenov; O V Glushkova; S M Lunin; S B Parfenyuk; T V Novoselova; E E Fesenko
Journal:  Mediators Inflamm       Date:  2014-06-19       Impact factor: 4.711

3.  The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials.

Authors:  Fang Liu; Hong-Mei Wang; Tiansheng Wang; Ya-Mei Zhang; Xi Zhu
Journal:  BMC Infect Dis       Date:  2016-09-15       Impact factor: 3.090

4.  Extrathymic production of thymulin induced by oxidative stress, heat shock, apoptosis, or necrosis.

Authors:  Sergey M Lunin; Maxim O Khrenov; Olga V Glushkova; Elena V Vinogradova; Valery A Yashin; Evgeny E Fesenko; Elena G Novoselova
Journal:  Int J Immunopathol Pharmacol       Date:  2017-02-01       Impact factor: 3.219

5.  Thymulin, free or bound to PBCA nanoparticles, protects mice against chronic septic inflammation.

Authors:  Elena G Novoselova; Sergey M Lunin; Olga V Glushkova; Maxim O Khrenov; Svetlana B Parfenyuk; Nadezhda M Zakharova; Evgeny E Fesenko
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

Review 6.  Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application.

Authors:  Martina Severa; Jing Zhang; Elena Giacomini; Fabiana Rizzo; Marilena Paola Etna; Melania Cruciani; Enrico Garaci; Michael Chopp; Eliana Marina Coccia
Journal:  Mult Scler Relat Disord       Date:  2018-10-02       Impact factor: 4.339

Review 7.  Thymus-Pineal Gland Axis: Revisiting Its Role in Human Life and Ageing.

Authors:  Rita Rezzani; Caterina Franco; Rüdiger Hardeland; Luigi Fabrizio Rodella
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

8.  An Investigation on the Therapeutic Effect of Thymosin β4 and Its Expression Levels in Streptozotocin-Induced Diabetic Mice.

Authors:  Kyung Sook Cho; Dong-Jin Kim; Bomee Shim; Jung Yeon Kim; Jun Mo Kang; Seon Hwa Park; Sang-Ho Lee; Hyung-In Yang; Kyoung Soo Kim
Journal:  Biomed Res Int       Date:  2018-08-27       Impact factor: 3.411

9.  Protective Effect of PBCA Nanoparticles Loaded with Thymulin Against the Relapsing-Remitting Form of Experimental Autoimmune Encephalomyelitis in Mice.

Authors:  Sergey M Lunin; Maxim O Khrenov; Olga V Glushkova; Svetlana B Parfenyuk; Tatyana V Novoselova; Elena G Novoselova
Journal:  Int J Mol Sci       Date:  2019-10-29       Impact factor: 5.923

Review 10.  An Overview of Peptide-Based Molecules as Potential Drug Candidates for Multiple Sclerosis.

Authors:  Annarita Del Gatto; Michele Saviano; Laura Zaccaro
Journal:  Molecules       Date:  2021-08-28       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.